Masakazu Toi

机构：Mukogawa Women's University, Hyogo Medical University, Kyoto University, Tokyo Metropolitan Komagome Hospital, Miyoshi Kasei (Japan) · ORCID：0000-0003-1488-9958

发表论文 1134 篇 · 总被引 43949 次 · h-index 88

代表论文

• Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer (2025 · New England Journal of Medicine · 被引 55)
• Extending the duration of endocrine treatment for early breast cancer: patient-level meta-analysis of 12 randomised trials of aromatase inhibitors in 22 031 postmenopausal women already treated with at least 5 years of endocrine therapy (2025 · The Lancet · 被引 32)
• Trastuzumab deruxtecan (T-DXd) + pertuzumab (P) vs taxane + trastuzumab + pertuzumab (THP) for first-line (1L) treatment of patients (pts) with human epidermal growth factor receptor 2–positive (HER2+) advanced/metastatic breast cancer (a/mBC): Interim results from DESTINY-Breast09. (2025 · Journal of Clinical Oncology · 被引 31)
• Subcutaneous/cutaneous uptake in the cancer-affected breast on 18F-FDG PET/CT: association with post-surgical prognosis in breast cancer patients (2025 · Annals of Nuclear Medicine · 被引 4)
• Locoregional indicators of systemic spread in breast cancer: insights from standard-of-care imaging and ¹⁸F-FDG PET/CT (2025 · Annals of Nuclear Medicine · 被引 2)
• Escalation and optimisation of primary breast cancer treatment with antibody-drug conjugates (2025 · Translational Breast Cancer Research · 被引 2)